{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-001270","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2021-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.102195+00:00","generated_at":"2026-06-29T15:39:35.243025+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeStance Health Q2 revenue $160.5M (+91% YoY), initiates FY2021 guidance","bullets":["Revenue $160.5M, up 91% YoY; net loss $70M includes $29.5M stock comp and $10M foundation endowment.","Adjusted EBITDA $14.5M (+39% YoY); total clinicians 3,975, up 94% YoY.","IPO completed June 10, net proceeds $548.9M used to retire debt and for corporate purposes.","FY2021 guidance: revenue $668M-$678M, Center Margin $198M-$208M, Adjusted EBITDA $47M-$53M.","Opened 35 de novo centers, entered 5 new states, completed 10 acquisitions in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-001270","json":"https://secwatch.observer/filing/0000950170-21-001270.json","markdown":"https://secwatch.observer/filing/0000950170-21-001270.md","text":"https://secwatch.observer/filing/0000950170-21-001270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017021001270/0000950170-21-001270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017021001270/lfst-20210811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T15:39:35.243025+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}